Health Care: Drugs

Ariad Pharmaceuticals (ARIA: NASDAQ)

$15.63 -0.08 | -0.51%
06/04/12 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 15.71
52 Week High 17.60
52 Week Low 7.55
Avg. Daily Vol. (Mil) 3.39
Beta (3 year) 1.75
Share Related Items
Mkt Cap (Mil) 2,603.60
Shares Out (Mil) 165.73
Float (Mil) 136.85
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 9.90
Current Ratio 10.00
LT Debt/ Equity 0.04
Total Debt / Equity 0.05
Valuation Ratios
Price Earnings n.a.
Price/Sales 102.80
Price/Book 10.12
Price/Cash Flow -19.00
Per Share Data
Earnings -0.99
Sales 0.15
Book Value 1.55
Cash Flow -0.83
Business Summary
Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
General Information
26 Landsdowne Street
Cambridge, MA 02139
www.ariad.com
Industry : Drugs
Sector: Health Care
Employees: 150
CEO: Dr. Harvey J. Berger,M.D
Short Interest
Current Month (Mil) 13.44
Previous Month (Mil) 14.16
Short Interest Ratio (Days) 3.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.60
Return on Investments -52.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARIA

Latest ARIA Headlines from TheStreet

More Financial News for ARIA

Press Releases for ARIA

See All Press Releases
Get started with stockpickr! Get recommendations from thousands of mutual funds, hedge funds, and others. Enter your favorite stocks now!
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter